Unicycive Therapeutics (UNCY) announced that it will implement a 1-for-10 reverse split of the issued shares of its common stock, effective at 4:01 p.m. Eastern Time on June 18, 2025. The Company’s common stock is expected to begin trading on a split-adjusted basis when the market opens on June 20, 2025, and will continue to trade on The Nasdaq Capital Market under the symbol “UNCY.” The new CUSIP number for the common stock will be 90466Y 202.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNCY:
- Why Is Unicycive Therapeutics Stock (UNCY) Down 35% Today?
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories
- Buy Rating for Unicycive Therapeutics: Strong Market Potential Despite Vendor Compliance Issue
- Unicycive Therapeutics Faces FDA Compliance Delay
- Unicycive Therapeutics provides update on NDA for oxylanthanum carbonate